BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1884902)

  • 1. Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects.
    Martin S; Schernthaner G; Nerup J; Gries FA; Koivisto VA; Dupré J; Standl E; Hamet P; McArthur R; Tan MH
    Diabetologia; 1991 Jun; 34(6):429-34. PubMed ID: 1884902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.
    Feutren G; Papoz L; Assan R; Vialettes B; Karsenty G; Vexiau P; Du Rostu H; Rodier M; Sirmai J; Lallemand A
    Lancet; 1986 Jul; 2(8499):119-24. PubMed ID: 2873396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
    Mandrup-Poulsen T; Mølvig J; Andersen HU; Helqvist S; Spinas GA; Munck M
    Diabetes; 1990 Feb; 39(2):204-10. PubMed ID: 2227128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin.
    Bougnères PF; Landais P; Boisson C; Carel JC; Frament N; Boitard C; Chaussain JL; Bach JF
    Diabetes; 1990 Oct; 39(10):1264-72. PubMed ID: 2210078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial Group.
    Diabetes; 1988 Nov; 37(11):1574-82. PubMed ID: 2903105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group.
    Petersen JS; Dyrberg T; Karlsen AE; Mølvig J; Michelsen B; Nerup J; Mandrup-Poulsen T
    Diabetes; 1994 Nov; 43(11):1291-6. PubMed ID: 7926302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials of cyclosporin in IDDM.
    Dupré J; Stiller CR; Gent M; Donner A; von Graffenried B; Heinrichs D; Jenner M; Keown P; Mahon J; Martell R
    Diabetes Care; 1988; 11 Suppl 1():37-44. PubMed ID: 3069390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunosuppression with cyclosporin induces clinical remission and improved beta cell function in patients with newly diagnosed insulin-dependent diabetes. A national and international multicenter study].
    Mandrup-Poulsen TR; Mølvig JC; Andersen V; Bendtzen K; Binder C; Brøns M; d'Amore FA; Dieperink H; Enk B; Frandsen NE
    Ugeskr Laeger; 1990 Jul; 152(27):1963-9. PubMed ID: 2195734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of cyclosporin A therapy in the early phase of type I diabetes mellitus].
    Schernthaner G; Aschauer-Treiber G; Gaube S; Klösch-Kasparek D; Müller C; Zielinski C
    Wien Klin Wochenschr; 1988 Jun; 100(13):454-9. PubMed ID: 3043916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinsulin and C-peptide at onset and during 12 months cyclosporin treatment of type 1 (insulin-dependent) diabetes mellitus.
    Snorgaard O; Hartling SG; Binder C
    Diabetologia; 1990 Jan; 33(1):36-42. PubMed ID: 2303172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma C-peptide levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulin.
    Assan R; Feutren G; Sirmai J; Laborie C; Boitard C; Vexiau P; Du Rostu H; Rodier M; Figoni M; Vague P
    Diabetes; 1990 Jul; 39(7):768-74. PubMed ID: 2191883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of erythropoietin is not responsible for the anaemia associated with cyclosporin treatment of insulin-dependent diabetes mellitus. Canadian-European Randomized Control Trial Group.
    Nielsen OJ; Mandrup-Poulsen T; Nerup J
    J Intern Med; 1993 Jun; 233(6):471-6. PubMed ID: 8501418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression in autoimmune disease: the double-edged sword.
    Jaworski MA; Jewell LD; Honore L; Mehta JG; Bayens-Simmonds J; McGuire-Clark P; Schouls JJ; Yap WY
    Clin Invest Med; 1987 Sep; 10(5):488-95. PubMed ID: 3315371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of cyclosporin A (CsA) in insulin-dependent diabetes in children and analysis of the secondary effects].
    Lévy-Marchal C; Tubiana-Rufi N; Czernichow P
    Journ Annu Diabetol Hotel Dieu; 1987; ():187-97. PubMed ID: 3613364
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus.
    Assan R; Feutren G; Debray-Sachs M; Quiniou-Debrie MC; Laborie C; Thomas G; Chatenoud L; Bach JF
    Lancet; 1985 Jan; 1(8420):67-71. PubMed ID: 2857024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Induction of remissions of insulin-dependent diabetes by cyclosporin].
    Feutren G; Papoz L; Assan R; Vialettes B; Pehuet M; Vexiau P; Durostu H; Rodier M; Sirmai J; Lallemand A
    C R Acad Sci III; 1986; 303(8):295-7. PubMed ID: 3094846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset.
    Stiller CR; Dupré J; Gent M; Jenner MR; Keown PA; Laupacis A; Martell R; Rodger NW; von Graffenried B; Wolfe BM
    Science; 1984 Mar; 223(4643):1362-7. PubMed ID: 6367043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin-A treatment for early insulin-dependent diabetes mellitus: first experience in Israel.
    Kisch ES; Yust I
    Isr J Med Sci; 1989 Jul; 25(7):414-6. PubMed ID: 2759840
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study.
    Parving HH; Tarnow L; Nielsen FS; Rossing P; Mandrup-Poulsen T; Osterby R; Nerup J
    Diabetes Care; 1999 Mar; 22(3):478-83. PubMed ID: 10097932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cyclosporine in recent-onset juvenile type 1 diabetes: impact of age and duration of disease.
    Stiller CR; Dupre J; Gent M; Heinrichs D; Jenner MR; Keown PA; Laupacis A; Martell R; Rodger NW; Wolfe BM
    J Pediatr; 1987 Dec; 111(6 Pt 2):1069-72. PubMed ID: 3316581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.